Endometrial Neoplasia

Gynecologic Pathology

Volumn , Issue , 2009, Pages 233-259

  Matias Guiu, Xavier ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882902463     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044306920-8.50011-0     Document Type: Chapter

References (21)

1. Ambros RA, Sherman ME, Zahn ChM, et al. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 1995, 26:1260-1267.
2. Baak JP, Mutter GL, Robboy S, et al. The molecular genetics and morphometry-based endometrial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer 2005, 103:2304-2312.
3. Bokhman JV Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983, 15:10-17.
4. Clement PhB, Young RH Endometrioid carcinoma of the uterus: a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2002, 3:145-184.
5. Goff BA, Kata D, Schmidt RA Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol 1994, 54:264-268.
6. Hendrickson MR, Ross J, Eifel P, et al. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982, 6:93-108.
7. Kurman RJ, Norris HJ Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well differentiated carcinoma. Cancer 1982, 49:2547-2559.
8. Kurman RJ, Kaminski PF, Norris HJ The behavior of endometrial hyperplasia. A long term study of "untreated" endometrial hyperplasia in 170 patients. Cancer 1985, 56:403-412.
9. Lax SF, Kurman RJ, Pizer ES, et al. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol 2000, 24:1201-1208.
10. Lee KR, Scully RE Complex endometrial hyperplasia and carcinoma in adolescents and young women 15 to 20 years of age. Int J Gynecol Pathol 1989, 8:201-213.
11. Longacre T, Chung MH, Jensen DN, et al. Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion. Am J Surg Pathol 1995, 19:371-406.
12. Mazur MT Atypical polypoid adenomyomas of the endometrium. Am J Surg Pathol 1981, 5:473-482.
13. Mutter GL, Baak JPA, Crum CP, et al. Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol 2000, 190:462-469.
14. Mutter GL, Kandeser J, Baak JPA, et al. Biopsy histomorphometry predicts uterine myoinvasion by endometrial carcinoma. A Gynecologic Oncology Group Study. Hum Pathol 2008, 39:866-874.
15. Mutter GL, Zaino RJ, Baak JP, et al. Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol 2007, 26:103-114.
16. Prat J Prognostic parameters of endometrial carcinoma. Hum Pathol 2004, 35:649-662.
17. Sherman ME, Bitterman P, Rosenshein NB, et al. Uterine serous carcinoma: a morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 1992, 16:600-610.
18. Soslow RA, Bissonnette JP, Wetton A, et al. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcome belie distinctive biologic differences. Am J Surg Pathol 2007, 31:979-987.
19. Tavasoli FA, Devilee P Pathology and Genetics of Tumours of the Breast and Female Organs. WHO Classification of Tumours 2003, IARC Press, Lyon.
20. Welch WR, Scully RE Precancerous lesions of the endometrium. Hum Pathol 1977, 8:503-512.
21. Wheeler DT, Bristow RE, Kurman RJ Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol 2007, 31:988-998.